Our study demonstrated that lncRNA SBF2-AS1 acted as a ceRNA to modulate the expression of ADAM17 through sponging miR-338-3p and exerted oncogenic roles during the progression of NSCLC (Figure 8J). Here, SBF2 is linked to non-small cell lung carcinoma.